Achievements in Systemic Therapies in the Pregenomic Era in Metastatic Breast Cancer
Open Access
- 1 March 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 12 (3) , 253-270
- https://doi.org/10.1634/theoncologist.12-3-253
Abstract
Learning Objectives: After completing this course, the reader will be able to: Identify the available systemic therapies for metastatic breast cancer patients.Define the role of taxanes and targeted therapies in metastatic breast cancer patients.Discuss the most useful endocrine therapy in patients with metastatic breast cancer. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.comKeywords
This publication has 97 references indexed in Scilit:
- Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancerEuropean Journal Of Cancer, 2004
- Is breast cancer survival improving?Cancer, 2003
- An open randomised trial of second-line endocrine therapy in advanced breast cancerEuropean Journal Of Cancer, 2003
- Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinomaCancer, 2003
- Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferencesEuropean Journal Of Cancer, 2003
- Treatment of Breast CancerNew England Journal of Medicine, 1998
- Characterisation of complete responders to combination chemotherapy for advanced breast cancer: A retrospective EORTC breast group studyEuropean Journal Of Cancer, 1996
- A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer *European Journal Of Cancer, 1996
- Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 monthsEuropean Journal Of Cancer, 1993
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896